CHYM Stock Chime Financial, Inc.

$30.34
1d-1.65%5d-9.57%1m-0.1%ytd+20.54%
At close · Nov 20, 4:00 PM ET
After hours $30.34 +0% · Nov 20, 6:14 PM ET
52w low $15.8874% of range$35.55 52w high
Price

Today’s call · CHYM

All live ideas →

3 of 6 technical checks lean bullish

CHYM is in an uptrend, momentum soft. $34.55 is the level overhead; $30 the first support below.

No open idea.Levels allow 12.4:1, but there is no confirmed entry yet — no breakout or pullback signal.
What would create one:
  • A close above $34.55 on rising volume (breakout).
  • A pullback to $30 that holds (entry near support).
Alert me at a level

The brief

Price vs 50-day · abovePrice vs 200-day · above50d vs 200d avg · aboveMACD · bearishRSI momentum · 475-day tape · -9.6%
signalCHYM’s 50-day average is above the 200-day — long-term trend alignment is bullish.
levelFirst support $30.0 is 1.12% below.
All readings
TrendUptrend · above 50-day & 200-day
MomentumRSI 46.6 · MACD bearish
Trend strengthADX 20.2 · developing
Location+1.7% vs 50-day MA
52-week range-12% from high · +85% from low
VolatilityATR 1.59 · ~5.2%/day
RSI 14
46.6
MACD
0.68
ADX 14
20.2
ATR 14
1.59
SMA 50
$29.82
SMA 200
$24.26

Levels that matter

$34.5552w high+13.9%
$35round+15.4%
$40round+31.8%
$30round−1.1%
$29.82sma 50−1.7%
$27.76swing zone · 3×−8.5%

Compare with…

Analyst overview · Nov 15

CHYM shares surge on strong relative performance and breakout potential

Chime Financial (CHYM) closed at $33.55 on November 13, a fresh high that sits just below its 52‑week peak and above the key $30 round support. The stock has outperformed the S&P 500 by more than 13% and the technology‑focused XLK ETF by over 22% in the past 50 days, reinforcing a bullish stance for the next two to six weeks. With price above its 40‑week average, a daily close above the $34.55 high on strong volume would confirm the upside breakout that the balance of evidence now leans toward.

Why it matters

The recent price action reflects a confluence of factors. First, the daily trend has aligned with the weekly uptrend, keeping the stock firmly above its 10‑week and 40‑week averages. This alignment signals that the recent rally is not a short‑term blip but part of a broader upward trajectory. Second, the relative strength numbers show CHYM leading the S&P 500 by 13.5% and XLK by 22.6% over the past 50 days, indicating that the stock’s gains are driven more by its own fundamentals than by sector or market tailwinds.

When the 5‑day performance is broken down, CHYM’s 7.09% gain dwarfs the market’s 2.59% rise and XLK’s 3.36% increase. The stock‑minus‑sector spread of roughly 3.7% confirms that the move is not merely a reflection of a tech rally; CHYM is generating its own upside. No specific news items have been released in the past week, so the market appears to have priced in the earnings beat from the November 5 report and the strong analyst consensus of a “strong buy” with a mean target of $41.90.

Analyst coverage is overwhelmingly positive: 21 analysts, a consensus of strong buy, and a mean target that sits about 20% above the current price. The low end of the target range at $34.0 is only a few cents above today’s price, while the high end of $50.0 provides a long‑term upside narrative. The valuation gap—price trading roughly 20% below the mean target—adds weight to the bullish case, even though the stock’s RSI of 70.5 suggests it is in overbought territory.

Debate around CHYM centers on two points. One side argues that the RSI above 70 signals a potential pull‑back, citing historical data where 58.7% of cases with a similar overbought reading saw a higher‑than‑average month later. The other side counters that the median one‑month move after such a signal is only +0.92%, indicating that the overbought condition has historically been a weak predictor of a reversal. Both perspectives are grounded in the same data set of 583 cases, but the modest median move tempers the bearish argument.

What the evidence says

On the long‑term horizon the thesis remains intact. The stock sits above its 40‑week average, the 200‑day SMA sits at $24.03, and the 52‑week high of $34.55 is still within reach. The upward bias is reinforced by a 70.5 RSI, a 56.2% volume surge over the 20‑day average, and an ATR of $1.42 that provides a reasonable cushion for stop placement.

Looking ahead to the next two‑to‑six weeks, the balance of evidence leans strongly positive. The assessment calls for a bullish stance with high conviction—three of four conviction points are met, driven by the daily‑weekly trend alignment and the stock’s outperformance versus both the market and its sector. The strongest case against this view is the overbought RSI, which historically can precede a modest pull‑back; however, the median one‑month move after such a signal is under 1%, insufficient to overturn the high‑conviction bullish reading.

Levels that matter

The structure holds above the round $30 level, which has acted as a firm floor since the trend began. A break below $30 would be the first crack in the structure, while a deeper decline toward the swing‑zone support at $24.8 would likely end the weekly uptrend. The $24.8 level is defined by a swing‑zone rule: a weekly close below that point would signal a shift in the picture.

The breakout math is anchored at the 52‑week high of $34.55. A daily close above that level on volume at least 56% above the 20‑day average would confirm the upside breakout. The stop is set at $29.64, derived from a round $30 minus a quarter of the $1.42 ATR. The first target is the round $35.0, offering a reward‑to‑risk of 0.1, while the next target at $40.0 provides a reward‑to‑risk of 1.1. Because the math does not achieve a 3‑to‑1 reward‑to‑risk ratio, a price move to roughly $45 would be needed to meet that threshold.

What would change the picture

A weekly close below the swing‑zone support at $24.8 would end the current uptrend and force a reassessment of the bullish thesis. The non‑price catalyst that could trigger such a shift would be a materially weaker earnings surprise or a downgrade from a major analyst, given the current consensus of strong buy.

What to watch

  • Next earnings release on November 5; the earnings‑per‑share (EPS) surprise relative to expectations will be the key number.
  • Sector‑wide developments, such as major cloud‑service contracts or regulatory changes affecting technology software, which could move XLK and, by extension, CHYM.
  • Valuation pressure: the stock trades about 20% below the mean analyst target of $41.90, providing a margin of safety that could be eroded if the consensus shifts.

MarketCrew is AI-powered and can make mistakes — double-check before acting. Informational only, not investment advice.